Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) have earned an average rating of "Moderate Buy" from the five analysts that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $342.00.
NUTX has been the topic of a number of analyst reports. B. Riley Financial lifted their price target on Nutex Health from $325.00 to $357.00 and gave the stock a "buy" rating in a research note on Monday, November 9th. Ladenburg Thalmann & Co. Inc. initiated coverage on Nutex Health in a report on Monday, October 26th. They set a "buy" rating and a $336.00 price target on the stock. Weiss Ratings downgraded Nutex Health from a "buy (b-)" rating to a "hold (c+)" rating in a report on Thursday, November 12th. Wall Street Zen raised shares of Nutex Health from a "hold" rating to a "buy" rating in a research report on Saturday, November 14th. Finally, Lake Street Capital lifted their target price on shares of Nutex Health from $310.00 to $333.00 and gave the company a "buy" rating in a research note on Monday, November 9th.
View Our Latest Research Report on Nutex Health
Nutex Health Trading Down 6.2%
Shares of NUTX stock opened at $162.10 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.72 and a current ratio of 4.76. Nutex Health has a 52-week low of $83.99 and a 52-week high of $226.16. The company has a market capitalization of $1.11 billion, a PE ratio of 6.92 and a beta of 0.66. The business's fifty day moving average is $200.34 and its 200 day moving average is $152.42.
Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.54 by $0.17. The company had revenue of $217.61 million during the quarter, compared to the consensus estimate of $214.82 million. Nutex Health had a net margin of 20.68% and a return on equity of 34.43%. On average, equities research analysts anticipate that Nutex Health will post 27.70 EPS for the current fiscal year.
Nutex Health Dividend Announcement
The company also recently disclosed a special dividend, which will be paid on Monday, December 14th. Shareholders of record on Monday, November 30th will be paid a dividend of $2.00 per share. The ex-dividend date is Monday, November 30th.
Insider Activity at Nutex Health
In related news, Director Scott Saunders sold 203 shares of the firm's stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the sale, the director owned 400 shares of the company's stock, valued at $85,700. This trade represents a 33.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 44.68% of the stock is currently owned by insiders.
Institutional Trading of Nutex Health
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Ruffer LLP bought a new position in shares of Nutex Health in the third quarter worth about $3,557,000. Virtu Financial LLC purchased a new position in Nutex Health in the third quarter valued at about $309,000. FORA Capital LLC acquired a new stake in shares of Nutex Health in the 3rd quarter worth $793,000. Empowered Funds LLC raised its holdings in shares of Nutex Health by 25.7% in the third quarter. Empowered Funds LLC now owns 56,806 shares of the company's stock worth $12,024,000 after buying an additional 11,629 shares during the last quarter. Finally, Private Advisor Group LLC purchased a new position in Nutex Health during the 3rd quarter worth approximately $1,184,000. Hedge funds and other institutional investors own 5.32% of the company's stock.
Nutex Health Company Profile
(
Get Free Report)
Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company's chairman and chief executive officer, Nutex operates in the United States.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.